The CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 9-13, 2009, attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating breast cancer.
Watch Dennis Slamon, M.D., Ph.D., director of clinical/translational research for the University of California, Los Angeles (UCLA) Revlon Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center. He is also a Stand Up To Cancer Dream Team Leader. Slamon presented updated results of his groundbreaking work with trastuzumab, currently sold as Herceptin by Genetech-Roche.
Download the video (49.3 MB file; 4:22 duration. Requires QuickTime to view).
Subscribe to the AACR Scientific Podcast feed through the following:
Subscribe to the AACR Scientific Podcast via a RSS Reader
Also, follow AACR throughout the meeting on Twitter @AACR, using the hash tag #SABCS09.
Subscribe to the AACR RSS News Feed.
Updated: Dec. 15, 2009